Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
• The company's antiviral drug development programmes remain central to investor attention.
• The company's proprietary dendrimer platform remains central to investor attention.
• The company continues advancing its biotechnology and regenerative medicine platform.
• The stock is down 28.91% over one year despite the company's commercial-stage transition.
• The stock is up 2.32% over one year, one of only two positive twelve-month records among sector large caps.
• The stock is down 59.17% over one year, the steepest fall among the sector's largest names.
• The stock remains down 49.95% over one year despite the day's advance.
• Fisher & Paykel Healthcare (ASX:FPH) shares rose 1.08% to $32.325, trading between $32.10 and $32.40.
• The stock is down 33.15% over one year despite the company's history of contract wins.
• The stock is up 13.90% over one year, one of the few positive twelve-month records among sector large caps.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…